Original Research
Published on 01 Aug 2024
Thoracic radiation in combination with erlotinib—results from a phase 2 randomized trial
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1412716
- 1,441 views
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,505 articles
Clinical Trial
Published on 31 Jul 2024
Phase II study of nab-paclitaxel with gemcitabine for relapsed/refractory small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1303268
- 1,642 views
Systematic Review
Published on 31 Jul 2024
Research trends in lung cancer and the tumor microenvironment: a bibliometric analysis of studies published from 2014 to 2023
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1428018
- 2,496 views
- 3 citations
Brief Research Report
Published on 24 Jul 2024
Relationship between nausea and vomiting and physical activity in patients with lung cancer undergoing first chemotherapy
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1396637
- 1,511 views
- 2 citations
Original Research
Published on 24 Jul 2024
CT morphological features and histogram parameters to predict micropapillary or solid components in stage IA lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1448333
- 1,019 views
Original Research
Published on 16 Jul 2024
Neoadjuvant targeted therapy versus targeted combined with chemotherapy for resectable EGFR-mutant non–small cell lung cancer: a retrospective controlled real-world study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1349300
- 1,987 views
Review
Published on 16 Jul 2024
Optimization of treatment strategies for elderly patients with advanced non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1384906
- 1,770 views
- 1 citation
Systematic Review
Published on 15 Jul 2024
Toxicity of immune checkpoint inhibitors and tyrosine kinase inhibitor combinations in solid tumours: a systematic review and meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1380453
- 2,764 views
- 2 citations
Original Research
Published on 12 Jul 2024
Association between obstructive sleep apnea and risk of lung cancer: findings from a collection of cohort studies and Mendelian randomization analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1346809
- 2,164 views
- 1 citation
Case Report
Published on 11 Jul 2024
Case report: Pathological complete response to neoadjuvant brigatinib in stage III non-small cell lung cancer with ALK rearrangement
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1343238
- 1,196 views
Review
Published on 11 Jul 2024
Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1387345
- 2,548 views
- 3 citations
Systematic Review
Published on 09 Jul 2024
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1415470
- 2,408 views
- 3 citations
Case Report
Published on 09 Jul 2024
A case report of recurrent testicular germ cell tumor in a patient with a history of primary pulmonary germ cell tumor and a review of the literature
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1361380
- 1,451 views
Original Research
Published on 09 Jul 2024
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1436588
- 3,710 views
- 5 citations
Original Research
Published on 08 Jul 2024
Camrelizumab combined with anlotinib as second-line therapy for metastatic or recurrent small cell lung cancer: a retrospective cohort study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1391828
- 1,201 views
- 1 citation
Case Report
Published on 08 Jul 2024
Challenges in the treatment of BRAF K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinib
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1374594
- 1,591 views